Summary
We report two patients with non-Hodgkin's lymphoma in whom hypercalcemia and elevated 1,25 dihydroxyvitamin D (1,25-(OH)2D3) levels developed in the absence of any lytic bone lesions. Hypercalcemia responded only transiently to glucocorticoids which were ill tolerated. Intravenous APD administration was needed to circumvene hypercalcemia. Humoral hypercalcemia of malignancy is discussed. Our cases confirm that hypercalcemia associated with elevated 1,25-(OH)2D3 may occur in malignant lymphoma.
Similar content being viewed by others
References
Canellos, G.P. Hypercalcemia in malignant lymphoma and leukemia. Ann NY Acad Sci 1974, 230, 240–246.
Rosenberg, S.A., Diamond, H.D., Jaslowitz, B., Craver, L.F. Lymphosarcoma: a review of 1269 cases. Medicine 1961, 40, 31–84.
Walker, I.R. Lymphoma with hypercalcemia. Can Med Assoc J 1974, 111, 928–930.
Shinoyama, M., Minato, K., Saito, H. et al. Comparison of clinical, morphologic and immunologic characteristics of adult T-cell leukemia-lymphoma. Jpn J Clin Oncol 1979, 9 (suppl.), 357–372.
Kinoshita, K., Kamihira, S., Ikeda, S., Yamada, Y., Muta, T., Kitamura, T., Ichimaru, M., Matsuo, T. Clinical, hematologic, and pathologic features of leukemic T-cell lymphoma. Cancer 1982, 50, 1554–1562.
Jaffe, E.S., Blattner, W.A., Blayney, D.W., Bunn, P.A., Cossman, J., Robert-Guroff, M., Gallo, R.C. The pathologic spectrum of adult T-cell leukemia/ lymphoma in the United States. Am J Surg Pathol 1984, 8, 263–275.
Mundy, G.R. Pathogenesis of hypercalcaemia of malignancy. Clin Endocrinol (Oxf), 1985, 23, 705–714.
Ralston, S.H. The pathogenesis of humoral hypercalcaemia of malignancy. Lancet 1987, ii, 1443–1446.
Breslau, N.A., McGuire, J.L., Zerwekh, J.E., Frenkel, E.P., Pak, C.Y.C. Hypercalcemia associated with increased serum calcitriol levels in three patients with lymphoma. Ann Intern Med 1984, 100, 1–7.
Needle, M.A., Chandra, B. Hypercalcemia, Hodgkin's disease, and calcitriol. Ann Intern Med 1984, 100, 916.
Rosenthal, N., Insogna, K.L., Godsall, J.W., Smaldone, L., Waldron, J.A., Stewart, A.F. Elevations in circulating 1,25-dihydroxyvitamin D in three patients with lymphoma-associated hypercalcemia. J Clin Endocrinol Metab 1985, 60, 29–33.
Zaloga, G.P., Eil, C., Medbery, C.A. Humoral hy- percalcemia in Hodgkin's disease. Arch Intern Med 1985, 145, 155–157.
Davies, M., Hayes, M.E., Mawer, E.B., Lumb, G.A. Abnormal vitamin D metabolism in Hodgkin's lymphoma. Lancet 1985, i, 1186–1188.
Lambrecht, L., Boelaert, J., Louwagie, A., Criel, A., Daneels, R., Bouillon, R. Hypercalcaemia in Hodgkin's disease. Acta Clin Belg 1986, 41, 37–42.
Adams, J.S., Fernandez, M., Gacad, M.A., Gill, P.S., Endres, D.B., Rasheed, S., Singer, F.R. Vitamin D metabolite-mediated hypercalcemia and hypercalciuria patients with AIDS — and non — AIDS — associated lymphoma. Blood 1989, 73, 235–239.
Helikson, M.A., Havey, A.D., Zerwekh, J.E., Breslau, N.A., Gardner, D.W. Plasma-cell granuloma producing calcitriol and hypercalcemia. Ann Intern Med 1986, 105, 379–381.
Mudde, A.H., van den Berg, H., Boshuis, P.G., Breedveld, F.C., Markusse, H.M., Kluin, P.M., Bijvoet, O.L.M., Papapoulos, S.E. Ectopic production of 1,25-dihydroxyvitamin D by B-cell lymphoma as a cause of hypercalcemia. Cancer 1987, 59, 1543–1546.
De Nayer, P., Thalasso, M., Beckers, C. Assay of 25-OH vitamin D3 in: Radioimmunoassay and Related Procedures in Medicine 1977. Vol II. Vienna, International Atomic Energy Agency, 199–209, 1978.
Reinhardt, T.A., Horst, R.L., Orf, J.W., Hollis, B.W. A microassay for 1,25-dihydroxyvitamin D not requiring high performance liquid chromatography: application to clinical studies. J Clin Endocrinol Metab 1984, 58, 91–98.
Huaux, J.P., Maldague, B., Deronde, T., Nagant de Deuxchaisnes, C., De Plaen, J.L. Toxicité osseuse de la vitamine A. A propos d'une observation. Louvain Med 1984, 103, 327–340.
Stern, P.H., De Olazabal, J., Bell, N.H. Evidence for abnormal regulation of circulating α, 25-dihydroxyvitamin D in patients with sacroidosis and normal calcium metabolism. J Clin Invest 1980, 66, 852–855.
Bell, N.H., Epstein, S., Shary, J., Greene, V., Oexmann, M.J., Shaw, S. Evidence of a probable role for 25-Hydroxyvitamin D in the regulation of human calcium metabolism. J Bone Miner Res 1988, 3, 489–495.
Sandler, L.M., Winearls, CG, Fraher, L.J., Clemens, T.L., Smith, R., O'Riordan, J.L.H. Studies of the hypercalcaemia of sarcoidosis: effect of steroids and exogenous vitamin D3 on the circulating concentrations of 1,25-Dihydroxyvitamin D3. Q J Med 1984, 53, 165–180.
Ralston, S.H., Cowan, R.A., Robertson, A.G., Gardner, M.D., Boyle, I.T. Circulating vitamin D metabolites and hypercalcaemia of malignancy. Acta Endocrinol 1984, 106, 556–563.
Ralston, S.H., Fogelman, I., Gardiner, M.D., Boyle, I.T. Relative contribution of humoral and metastatic factors to the pathogenesis of hypercalcaemia in malignancy. Br Med J 1984, 288, 1405–1408.
Raisz, L.G., Trummel, C.L., Holick, M.F., DeLuca, H.F. 1,25-dihydroxycholecalciferol: a potent stimulator of bone resorption in tissue culture. Science 1972, 175, 768–769.
Mundy, G.R. Hypercalcemia of malignancy revisited. J Clin Invest 1988, 82, 1–6.
Burtis, W.J., Wu, T.L., Insogna, K.L., Stewart, A.F. Humoral hypercalcemia of malignancy. Ann Intern Med 1988, 108, 454–457.
Mundy, G.R., Ibbotson, K.J., D'Souza, S.M. Tumor products and the hypercalcemia of malignancy. J Clin Invest 1985, 76, 391–394.
DeRemee, R.A., Banks, P.M. Non-Hodgkin's lymphoma associated with hypercalcemia and increased activity of serum angiotensin-converting enzyme. Mayo Clin Proc 1986, 61, 714–718.
Chesney, R.W., Hamstra, A.J., DeLuca, H.F., Horowitz, S., Gilbert, E.F., Hong, R., Borcherding, W. Elevated serum 1,25-dihydroxyvitamin D concentrations in the hypercalcemia of sarcoidosis: correction by glucocorticoid therapy. J Pediatr 1981, 98, 919–922.
Huaux, J.P., Noël, H., Bastien, P., Doyen, C., Nagant de Deuxchaisnes, C. Les lésions osseuses de la leucémie à tricholeucocytes. Quelques considérations thérapeutiques. A propos d'une observation. Acta Clin Belg 1984, 39, 339–351.
Harinck, H.I.J, Bijvoet, O.L.M, Plantingh, A.S.T., Body, J.J., Elte, J.W., Sleeboom, H.P., Wildiers, J., Neijt, J.P. Role of bone and kidney in tumor — induced hypercalcemia and its treatment with bisphosphonate and sodium chloride. Am J Med 1987, 82, 1133–1142.
Noël, H., Helbron, D., Lennert, K. Epithelioid cellular lymphogranulomatosis (lymphoepithelioid cell lymphoma): histologic and clinical observations. Eds: van den Tweel, J.G., Taylor, C.R., Bosman, F.T. In: Malignant Lymphoproliferative Diseases. Leiden University Press, The Hague 1980, 433–445.
Barbour, G.L., Coburn, J.W., Slatopolsky, E., Norman, A.W., Horst, R.L. Hypercalcemia in an anephric patient with sarcoidosis: evidence for extrarenal generation of 1,25-dihydroxyvitamin D. N Engl J Med 1981, 305, 440–443.
Mason, R.S., Frankel, T., Chan, Y-L., Lissner, D., Posen, S. Vitamin D conversion by sarcoid lymph node homogenate. Ann Intern Med 1984, 100, 59–61.
Adams, J.S., Sharma, O.P., Gacad, M.A., Singer, F.R. Metabolism of 25-hydroxyvitamin D3 by cultured pulmonary alveolar macrophages in sarcoidosis. J Clin Invest 1983, 72, 1856–1860.
Choe, J.K., Hyun, B.H., Salazar, G.H., Ashton, J.K., Sung, C. Epithelioid granulomas of the bone marrow in non-Hodgkin's lymphoproliferative malignancies. Am J Clin Pathol 1984, 81, 19–24.
Dodd, R.C., Winkler, C.F., Williams, M.E., Bunn, P.A., Gray, T.K. Calcitriol levels in hypercalcemic patients with adult T-cell lymphoma. Arch Intern Med 1986, 146, 1971–1972.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Devogelaer, J.P., Lambert, M., Boland, B. et al. 1,25-Dihydroxyvitamin D-related hypercalcemia in lymphoma: Two case reports. Clin Rheumatol 9, 404–410 (1990). https://doi.org/10.1007/BF02114405
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02114405